Nuclear Medicine Methods in Scrotal Imaging

  • Giuseppe Caruso
  • Giuseppe Salvaggio
  • Artor Niccoli Asabella
  • S. Carluccio
  • Giuseppe Rubini
Part of the Medical Radiology book series (MEDRAD)


In patients with acute scrotal pain scrotal scintigraphy can be used to exclude torsion of the testicle, which presents with unilateral decrease in activity on the affected side.The role of nuclear medicine methods, however, faded in the last years after the introduction of high performance color Doppler ultrasound equipment. Lymphoscintigraphy can be used in patients with testicular cancer to demonstrate the lymphatic drainage pathway of the neoplasm. Several studies suggest that 18FDG-PET/CT might have a role in the staging germ cell tumors, in identification of recurrent/residual disease, to monitor the treatment response and during the follow-up. Other investigations, however, did not confirm these results.


Sentinel Node Germ Cell Tumor Testicular Cancer Lymphatic Mapping Mature Teratoma 



The authors thank Vincenzo Allegri, Valentina Ambrosini and Stefano Fanti of the Department of Nuclear Medicine, S. Orsola Malpighi Hospital, Bologna, for their contribution.


  1. Albers P, Bender H, Yilmaz H et al (1999) Positron emission tomography in the clinical staging of patients with Stage I and II testicular germ cell tumors. Urology 53:808–811PubMedCrossRefGoogle Scholar
  2. Aso C, Enriquez G, Fite M et al (2005) Gray-scale and color Doppler sonography of scrotal disorders in children: an update. Radiographics 25:1197–1214PubMedCrossRefGoogle Scholar
  3. Bekerman C, Hoffer PB, Bitran JD (1984) The role of gallium-67 in the clinical evaluation of cancer. Semin Nucl Med 14:296–323PubMedCrossRefGoogle Scholar
  4. Cremerius U, Effert PJ, Adam G et al (1998) FDG PET for detection and therapy control of metastatic germ cell tumor. J Nucl Med 39:815–822PubMedGoogle Scholar
  5. Cremerius U, Wildberger JE, Borchers H et al (1999) Does positron emission tomography using 18-fluoro-2-deoxyglucose improve clinical staging of testicular cancer? Results of a study in 50 patients. Urology 54:900–904PubMedCrossRefGoogle Scholar
  6. De Santis M, Bokemeyer C, Becherer A et al (2001) Predictive impact of 2–18fluoro-2-deoxy-d-glucose positron emission tomography for residual postchemotherapy masses in patients with bulky seminoma. J Clin Oncol 19:3740–3744PubMedGoogle Scholar
  7. De Santis M, Becherer A, Bokemeyer C et al (2004) 2–18fluoro-deoxy-d-glucose positron emission tomography is a reliable predictor for viable tumor in postchemotherapy seminoma: an update of the prospective multicentric SEMPET trial. J Clin Oncol 22:1034–1039PubMedCrossRefGoogle Scholar
  8. Goldfarb LR, Alazraki NP, Eshima D, et al (1998) Lymphoscintigraphic identification of sentinel lymph nodes: clinical evaluation of 0.22-micron filtration of Tc-99 m sulfur colloid. Radiology, 208:505–509Google Scholar
  9. Hain SF, O’Doherty MJ, Timothy AR et al (2000a) Fluorodeoxyglucose PET in the initial staging of germ cell tumours. Eur J Nucl Med 27:590–594PubMedCrossRefGoogle Scholar
  10. Hain SF, O’Doherty MJ, Timothy AR et al (2000b) Fluorodeoxyglucose positron emission tomography in the evaluation of germ cell tumours at relapse. Br J Cancer 83:863–869PubMedCrossRefGoogle Scholar
  11. Hinz S, Schrader M, Kempkensteffen C et al (2008) The role of positron emission tomography in the evaluation of residual masses after chemotherapy for advanced stage seminoma. J Urol 179:936–940 discussion 940PubMedCrossRefGoogle Scholar
  12. Jackson FI, Dierich HC, Lentle BC (1976) Gallium-67 citrate scintiscanning in testicular neoplasia. J Can Assoc Radiol 27:84–88PubMedGoogle Scholar
  13. MacDonald A, Burrell S (2009) Infrequently performed studies in nuclear medicine: part 2. J Nucl Med Technol 37:1–13PubMedCrossRefGoogle Scholar
  14. Nadel NS, Gitter MH, Hahn LC et al (1973) Preoperative diagnosis of testicular torsion. Urology 1:478–479PubMedCrossRefGoogle Scholar
  15. Nuutinen JM, Leskinen S, Elomaa I et al (1997) Detection of residual tumours in postchemotherapy testicular cancer by FDG-PET. Eur J Cancer 33:1234–1241PubMedCrossRefGoogle Scholar
  16. Oechsle K, Hartmann M, Brenner W et al (2008) [18F]Fluorodeoxyglucose positron emission tomography in nonseminomatous germ cell tumors after chemotherapy: the German multicenter positron emission tomography study group. J Clin Oncol 26:5930–5935PubMedCrossRefGoogle Scholar
  17. Paltiel HJ, Connolly LP, Atala A et al (1998) Acute scrotal symptoms in boys with an indeterminate clinical presentation: comparison of color Doppler sonography and scintigraphy. Radiology 207:223–231PubMedGoogle Scholar
  18. Paterson AH, Peckham MJ, McCready VR (1976) Value of gallium scanning in seminoma of the testis. Br Med J 1:1118–1121PubMedCrossRefGoogle Scholar
  19. Sauerbrunn BJ, Andrews GA, Hubner KF (1978) Ga-67 citrate imaging in tumors of the genito-urinary tract: report of cooperative study. J Nucl Med 19:470–475PubMedGoogle Scholar
  20. Spermon JR, De Geus-Oei LF, Kiemeney LA et al (2002) The role of (18)fluoro-2-deoxyglucose positron emission tomography in initial staging and re-staging after chemotherapy for testicular germ cell tumours. BJU Int 89:549–556PubMedCrossRefGoogle Scholar
  21. Stephens AW, Gonin R, Hutchins GD et al (1996) Positron emission tomography evaluation of residual radiographic abnormalities in postchemotherapy germ cell tumor patients. J Clin Oncol 14:1637–1641PubMedGoogle Scholar
  22. Stomper PC, Kalish LA, Garnick MB et al (1991) CT and pathologic predictive features of residual mass histologic findings after chemotherapy for nonseminomatous germ cell tumors: can residual malignancy or teratoma be excluded? Radiology 180:711–714PubMedGoogle Scholar
  23. Strauss LG, Conti PS (1991) The applications of PET in clinical oncology. J Nucl Med 32:623–648 discussion 649-650PubMedGoogle Scholar
  24. Sugawara Y, Zasadny KR, Grossman HB et al (1999) Germ cell tumor: differentiation of viable tumor, mature teratoma, and necrotic tissue with FDG PET and kinetic modeling. Radiology 211:249–256PubMedGoogle Scholar
  25. Symmonds RE, Tauxe WN (1972) Gallium-67 scintigraphy of gynecologic tumors. Am J Obstet Gynecol 114:356–369PubMedGoogle Scholar
  26. Tanis PJ, Horenblas S, Valdes Olmos RA et al (2002) Feasibility of sentinel node lymphoscintigraphy in stage I testicular cancer. Eur J Nucl Med Mol Imaging 29:670–673PubMedCrossRefGoogle Scholar
  27. Toner GC, Panicek DM, Heelan RT et al (1990) Adjunctive surgery after chemotherapy for nonseminomatous germ cell tumors: recommendations for patient selection. J Clin Oncol 8:1683–1694PubMedGoogle Scholar
  28. Tsatalpas P, Beuthien-Baumann B, Kropp J et al (2002) Diagnostic value of 18F-FDG positron emission tomography for detection and treatment control of malignant germ cell tumors. Urol Int 68:157–163PubMedCrossRefGoogle Scholar
  29. Uchiyama M, Kantoff PW, Kaplan WD (1994) Gallium-67-citrate imaging in extragonadal and gonadal seminomas: relationship to radiologic findings. J Nucl Med 35:1624–1630PubMedGoogle Scholar
  30. Warren GP, Einhorn LH (1995) Gallium scans in the evaluation of residual masses after chemotherapy for seminoma. J Clin Oncol 13:2784–2788PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2011

Authors and Affiliations

  • Giuseppe Caruso
    • 1
  • Giuseppe Salvaggio
    • 1
  • Artor Niccoli Asabella
    • 2
  • S. Carluccio
    • 3
  • Giuseppe Rubini
    • 2
  1. 1.Department of RadiologyUniversity of PalermoPalermoItaly
  2. 2.Department of Nuclear MedicineUniversity of BariBariItaly
  3. 3.Department of Nuclear MedicineVilla Sofia HospitalPalermoItaly

Personalised recommendations